KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to $51.9 million.

  • Dynavax Technologies' Accumulated Expenses fell 4.09% to $51.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.9 million, marking a year-over-year decrease of 4.09%. This contributed to the annual value of $61.1 million for FY2024, which is 23.50% up from last year.
  • Latest data reveals that Dynavax Technologies reported Accumulated Expenses of $51.9 million as of Q3 2025, which was down 21.32% from $66.0 million recorded in Q2 2025.
  • Dynavax Technologies' Accumulated Expenses' 5-year high stood at $87.9 million during Q3 2021, with a 5-year trough of $16.1 million in Q1 2021.
  • Over the past 3 years, Dynavax Technologies' median Accumulated Expenses value was $49.4 million (recorded in 2023), while the average stood at $48.7 million.
  • In the last 5 years, Dynavax Technologies' Accumulated Expenses skyrocketed by 411.34% in 2021 and then crashed by 56.54% in 2022.
  • Over the past 5 years, Dynavax Technologies' Accumulated Expenses (Quarterly) stood at $49.8 million in 2021, then plummeted by 38.31% to $30.7 million in 2022, then skyrocketed by 60.97% to $49.4 million in 2023, then climbed by 23.50% to $61.1 million in 2024, then decreased by 4.09% to $51.9 million in 2025.
  • Its Accumulated Expenses stands at $51.9 million for Q3 2025, versus $66.0 million for Q2 2025 and $54.3 million for Q1 2025.